1012059-54-9 Usage
General Description
The chemical "1H-IMidazo[4,5-c]pyridin-4-aMine, 2-[(6-broMo-1,3-benzodioxol-5-yl)thio]-1-[(4-Methoxyphenyl)Methyl]" is a compound with a complex molecular structure. It contains an imidazo[4,5-c]pyridin-4-amine core, with a thio group attached to the benzodioxol ring and a 4-methoxyphenylmethyl group attached to the imidazo ring. The presence of the bromine and methoxy groups adds to its reactivity and potential pharmacological activity. 1H-IMidazo[4,5-c]pyridin-4-aMine, 2-[(6-broMo-1,3-benzodioxol-5-yl)thio]-1-[(4-Methoxyphenyl)Methyl] may have potential applications in medicinal chemistry and drug development due to its unique structure and functional groups. Further research and analysis are necessary to fully understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 1012059-54-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,2,0,5 and 9 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1012059-54:
(9*1)+(8*0)+(7*1)+(6*2)+(5*0)+(4*5)+(3*9)+(2*5)+(1*4)=89
89 % 10 = 9
So 1012059-54-9 is a valid CAS Registry Number.
1012059-54-9Relevant articles and documents
Fused Amino Pyridines for the Treatment of Lung Cancer
-
Paragraph 0154, (2016/11/17)
The present invention relates to the use of compounds with fused amino pyridine core for the treatment of malignancies associated with brain and lung. The oral administration of compounds of the instant application results in effective brain penetration and provides for non-intrusive treatment of brain and lung tumors.
FUSED AMINO PYRIDINES FOR THE TREATMENT OF BRAIN TUMORS
-
, (2010/08/07)
The present invention relates to the use of compounds with fused amino pyridine core for the treatment of malignancies associated with brain and lung. The oral administration of compounds of the instant application results in effective brain penetration and provides for non-intrusive treatment of brain and lung tumors.
FUSED AMINO PYRIDINE AS HSP90 INHIBITORS
-
Page/Page column 44, (2008/12/08)
The present invention relates to HSP90 inhibitors containing fused amino pyridine core that are useful as inhibitors of HSP90 and their use in the treatment of HSP90 related diseases and disorders such as cancer, an autoimmune disease, or a neurodegenerative disease.